Go to:
Logótipo
Você está em: Start > Publications > View > Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?
Map of Premises
Principal
Publication

Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?

Title
Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?
Type
Another Publication in an International Scientific Journal
Year
2022
Authors
Machado, V
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Morais, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rui Medeiros
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Title: PharmaceuticsImported from Authenticus Search for Journal Publications
Vol. 14 No. 3
Final page: 2092
ISSN: 1999-4923
Publisher: MDPI
Other information
Authenticus ID: P-00X-F2T
Abstract (EN): Cancer cells normally develop the ability to rewire or reprogram themselves to become resistant to treatments that were previously effective. Despite progress in understanding drug resistance, knowledge gaps remain regarding the underlying biological causes of drug resistance and the design of cancer treatments to overcome it. So, resistance acquisition remains a major problem in cancer treatment. Targeted therapeutics are considered the next generation of cancer therapy because they overcome many limitations of traditional treatments. Numerous tumor cells overexpress several receptors that have a high binding affinity for hyaluronic acid (HA), while they are poorly expressed in normal body cells. HA and its derivatives have the advantage of being biocompatible and biodegradable and may be conjugated with a variety of drugs and drug carriers for developing various formulations as anticancer therapies such as micelles, nanogels, and inorganic nanoparticles. Due to their stability in blood circulation and predictable delivery patterns, enhanced tumor-selective drug accumulation, and decreased toxicity to normal tissues, tumor-targeting nanomaterial-based drug delivery systems have been shown to represent an efficacious approach for the treatment of cancer. In this review, we aim to provide an overview of some in vitro and in vivo studies related to the potential of HA as a ligand to develop targeted nanovehicles for future biomedical applications in cancer treatment.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 34
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Second-Generation Antimitotics in Cancer Clinical Trials (2021)
Another Publication in an International Scientific Journal
Novais, P; Silva, PMA; Maria Isabel Amorim; Bousbaa, H
Research Models to Study Ferroptosis's Impact in Neurodegenerative Diseases (2023)
Another Publication in an International Scientific Journal
Fernanda Borges
Red Seaweed-Derived Compounds as a Potential New Approach for Acne Vulgaris Care (2021)
Another Publication in an International Scientific Journal
Januario, AP; Felix, R; Felix, C; Reboleira, J; Patricia Valentao; Lemos, MFL
Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies (2020)
Another Publication in an International Scientific Journal
Teixeira, MI; Maria Helena Amaral; Paulo Costa; Lopes, CM; Lamprou, DA
Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence (2020)
Another Publication in an International Scientific Journal
Menditto, E; Orlando, V; De Rosa, G; Minghetti, P; Musazzi, UM; Cahir, C; Kurczewska Michalak, M; Kardas, P; Costa, E; Sousa Lobo JM; Almeida, IF

See all (107)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2025-07-03 at 23:51:30 | Acceptable Use Policy | Data Protection Policy | Complaint Portal